167 related articles for article (PubMed ID: 18797424)
1. Utilization and determinants of adjuvant therapy among older patients who receive curative surgery for pancreatic cancer.
Davila JA; Chiao EY; Hasche JC; Petersen NJ; McGlynn KA; Shaib YH
Pancreas; 2009 Jan; 38(1):e18-25. PubMed ID: 18797424
[TBL] [Abstract][Full Text] [Related]
2. Evidence for treatment and survival disparities by age in pancreatic adenocarcinoma: a population-based analysis.
Amin S; Lucas AL; Frucht H
Pancreas; 2013 Mar; 42(2):249-53. PubMed ID: 22836862
[TBL] [Abstract][Full Text] [Related]
3. Multimodality therapy for pancreatic cancer in the U.S. : utilization, outcomes, and the effect of hospital volume.
Bilimoria KY; Bentrem DJ; Ko CY; Tomlinson JS; Stewart AK; Winchester DP; Talamonti MS
Cancer; 2007 Sep; 110(6):1227-34. PubMed ID: 17654662
[TBL] [Abstract][Full Text] [Related]
4. Analysis of radiotherapy impact on survival in resected stage I/II pancreatic cancer patients: a population-based study.
Han D; Gao F; Liu JL; Wang H; Fu Q; Yang GW
BMC Cancer; 2021 May; 21(1):560. PubMed ID: 34001035
[TBL] [Abstract][Full Text] [Related]
5. The impact of curative intent surgery on the survival of pancreatic cancer patients: a U.S. Population-based study.
Shaib Y; Davila J; Naumann C; El-Serag H
Am J Gastroenterol; 2007 Jul; 102(7):1377-82. PubMed ID: 17403071
[TBL] [Abstract][Full Text] [Related]
6. Equivalent Treatment and Survival after Resection of Pancreatic Cancer at Safety-Net Hospitals.
Dhar VK; Hoehn RS; Kim Y; Xia BT; Jung AD; Hanseman DJ; Ahmad SA; Shah SA
J Gastrointest Surg; 2018 Jan; 22(1):98-106. PubMed ID: 28849353
[TBL] [Abstract][Full Text] [Related]
7. Pancreatic cancer in the USA: persistence of undertreatment and poor outcome.
Enewold L; Harlan LC; Tucker T; McKenzie S
J Gastrointest Cancer; 2015 Mar; 46(1):9-20. PubMed ID: 25403828
[TBL] [Abstract][Full Text] [Related]
8. Breast cancer among the oldest old: tumor characteristics, treatment choices, and survival.
Schonberg MA; Marcantonio ER; Li D; Silliman RA; Ngo L; McCarthy EP
J Clin Oncol; 2010 Apr; 28(12):2038-45. PubMed ID: 20308658
[TBL] [Abstract][Full Text] [Related]
9. Trajectory of care and use of multimodality therapy in older patients with pancreatic adenocarcinoma.
Parmar AD; Vargas GM; Tamirisa NP; Sheffield KM; Riall TS
Surgery; 2014 Aug; 156(2):280-9. PubMed ID: 24851723
[TBL] [Abstract][Full Text] [Related]
10. External radiation is associated with limited improvement in overall survival in resected margin-negative stage IIB pancreatic adenocarcinoma.
Kantor O; Talamonti MS; Lutfi W; Wang CH; Winchester DJ; Marsh R; Prinz RA; Baker MS
Surgery; 2016 Dec; 160(6):1466-1476. PubMed ID: 27614417
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of Treatment Patterns and Survival Outcomes in Elderly Pancreatic Cancer Patients: A Surveillance, Epidemiology, and End Results-Medicare Analysis.
Shaib WL; Jones JS; Goodman M; Sarmiento JM; Maithel SK; Cardona K; Kane S; Wu C; Alese OB; El-Rayes BF
Oncologist; 2018 Jun; 23(6):704-711. PubMed ID: 29445028
[TBL] [Abstract][Full Text] [Related]
12. Postoperative mortality following multi-modality therapy for pancreatic cancer: Analysis of the SEER-Medicare data.
Nayar P; Chandak A; Gupta N; Yu F; Qiu F; Ganti AK; Are C
J Surg Oncol; 2017 Feb; 115(2):158-163. PubMed ID: 28133817
[TBL] [Abstract][Full Text] [Related]
13. Racial disparities in treatment and survival of male breast cancer.
Crew KD; Neugut AI; Wang X; Jacobson JS; Grann VR; Raptis G; Hershman DL
J Clin Oncol; 2007 Mar; 25(9):1089-98. PubMed ID: 17369572
[TBL] [Abstract][Full Text] [Related]
14. Overall survival is increased among stage III pancreatic adenocarcinoma patients receiving neoadjuvant chemotherapy compared to surgery first and adjuvant chemotherapy: An intention to treat analysis of the National Cancer Database.
Shubert CR; Bergquist JR; Groeschl RT; Habermann EB; Wilson PM; Truty MJ; Smoot RL; Kendrick ML; Nagorney DM; Farnell MB
Surgery; 2016 Oct; 160(4):1080-1096. PubMed ID: 27522556
[TBL] [Abstract][Full Text] [Related]
15. Underuse of surgical resection among elderly patients with early-stage pancreatic cancer.
He W; Zhao H; Chan W; Lopez D; Shroff RT; Giordano SH
Surgery; 2015 Nov; 158(5):1226-34. PubMed ID: 26138347
[TBL] [Abstract][Full Text] [Related]
16. Pancreatic Carcinosarcoma Clinical Outcome Analysis of the National Cancer Institute Database.
Alhatem A; Quinn PL; Xia W; Chokshi RJ
J Surg Res; 2021 Mar; 259():62-70. PubMed ID: 33279845
[TBL] [Abstract][Full Text] [Related]
17. Initiation of adjuvant therapy following surgical resection of pancreatic ductal adenocarcinoma (PDAC): Are patients from rural, remote areas disadvantaged?
Bertens KA; Massman JD; Helton S; Garbus S; Mandelson MM; Lin B; Picozzi VJ; Biehl T; Alseidi AA; Rocha FG
J Surg Oncol; 2018 Jun; 117(8):1655-1663. PubMed ID: 29761510
[TBL] [Abstract][Full Text] [Related]
18. Neoadjuvant radiation followed by resection versus upfront resection for locally advanced pancreatic cancer patients: a propensity score matched analysis.
Chen X; Liu G; Wang K; Chen G; Sun J
Oncotarget; 2017 Jul; 8(29):47831-47840. PubMed ID: 28599299
[TBL] [Abstract][Full Text] [Related]
19. A comparative analysis of survival outcomes between pancreatectomy and chemotherapy for elderly patients with adenocarcinoma of the pancreas.
Marmor S; Burke EE; Virnig BA; Jensen EH; Tuttle TM
Cancer; 2016 Nov; 122(21):3378-3385. PubMed ID: 27419382
[TBL] [Abstract][Full Text] [Related]
20. Determinants of adjuvant oxaliplatin receipt among older stage II and III colorectal cancer patients.
Lund JL; Stürmer T; Sanoff HK; Brookhart A; Sandler RS; Warren JL
Cancer; 2013 Jun; 119(11):2038-47. PubMed ID: 23512326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]